Gonzalez Marcos R, Lim Perry L, Chen Antonia F, Melnic Christopher M, Bedair Hany S
Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Orthopaedic Surgery, Newton-Wellesley Hospital, Newton, Massachusetts.
J Arthroplasty. 2025 Mar;40(3):637-643. doi: 10.1016/j.arth.2024.08.039. Epub 2024 Aug 30.
Differences in patient-reported outcome measures (PROMs) between manual total knee arthroplasty (mTKA) and robotic-assisted TKA (rTKA) have not been adequately assessed. We compared the minimal clinically important difference (MCID) for improvement (MCID-I) and worsening (MCID-W) between mTKA and rTKA patients.
Patients who underwent primary TKA (874 mTKA and 439 rTKA) with complete preoperative and 1-year postoperative PROMs were retrospectively identified using a multihospital joint arthroplasty registry. Patient-Reported Outcomes Measurement Information System Physical Function Short Form 10a (PROMIS PF-10a), PROMIS Global - Physical, or Knee Injury and Osteoarthritis Outcome Score-Physical Function Short Form were collected. The MCID-I, MCID-W, and "no significant change" rates were calculated using distribution-based methods. Propensity score matching was performed to control for confounding.
Similar 90-day pulmonary embolism (P = 0.26), deep venous thrombosis (P = 0.67), and emergency department visit (P = 0.35) rates were found. The 90-day readmission rate for mTKA was 1.7 and 3.4% for rTKA (P = 0.08), and the overall revision rates were 2.2% for mTKA and 0.7% for rTKA (P = 0.07). Revision-free survival was 99% at one and 2 years for both groups (P = 0.65 and P = 0.43, respectively). There were no differences in the proportion of patients achieving MCID-I or MCID-W for PROMIS PF-10a, PROMIS Global - Physical, or Knee Injury and Osteoarthritis Outcome Score-Physical Function Short Form. The MCID-I for PROMIS PF-10a was achieved in 65.5 and 62.2% of patients who had mTKA and rTKA, respectively (P = 0.32).
Our study demonstrated similar complication rates and MCID-I and MCID-W attainment rates between mTKA and rTKA patients. Future studies should assess MCID attainment rates in the long term and in larger cohorts comparing mTKA and rTKA.
人工全膝关节置换术(mTKA)和机器人辅助全膝关节置换术(rTKA)之间患者报告的结局指标(PROMs)差异尚未得到充分评估。我们比较了mTKA和rTKA患者改善的最小临床重要差异(MCID-I)和恶化的最小临床重要差异(MCID-W)。
使用多医院关节置换登记系统回顾性确定接受初次全膝关节置换术(874例mTKA和439例rTKA)且术前和术后1年PROMs完整的患者。收集患者报告的结局测量信息系统身体功能简表10a(PROMIS PF-10a)、PROMIS全球身体状况或膝关节损伤与骨关节炎结局评分身体功能简表。使用基于分布的方法计算MCID-I、MCID-W和“无显著变化”率。进行倾向得分匹配以控制混杂因素。
发现90天肺栓塞(P = 0.26)、深静脉血栓形成(P = 0.67)和急诊就诊(P = 0.35)率相似。mTKA的90天再入院率为1.7%,rTKA为3.4%(P = 0.08),总体翻修率mTKA为2.2%,rTKA为0.7%(P = 0.07)。两组在1年和2年时无翻修生存率均为99%(分别为P = 0.65和P = 0.43)。在PROMIS PF-10a、PROMIS全球身体状况或膝关节损伤与骨关节炎结局评分身体功能简表方面,达到MCID-I或MCID-W的患者比例没有差异。接受mTKA和rTKA的患者中,分别有65.5%和62.2%达到了PROMIS PF-10a的MCID-I(P = 0.32)。
我们的研究表明,mTKA和rTKA患者的并发症发生率以及MCID-I和MCID-W达成率相似。未来的研究应在更大的队列中比较mTKA和rTKA,并长期评估MCID达成率。